PRA International has partnered with LSK Global Pharma Services of South Korea and Mediscience Planning in Japan to reach further into the clinical research in southwest Asia. They've been working with the region since 2004, in countries such as Australia, New Zealand, Singapore, Hong Kong and Taiwan.
Edward Ian, the senior director of clinical operations for PRA Asia Pacific had this to say about expanding into Japan:
“It really depends on the needs of the Japanese pharma. If they need a clinical program to be done in three countries only—Japan, Korea and Taiwan—that’s great. If they have needs to take the projects to China or Singapore, then PRA’s regional help in Asia-Pacific will be able to come in. It’s a global level of clinical trial management services for those Japanese companies that may have more than regional study needs.”
Source: Clinical Trials Today
Search This Blog
Blog Archive
-
▼
2009
(141)
-
▼
February
(16)
- February Edition of Partnerships with CROs LinkedI...
- Unethical Clinical Trial Outsourcing
- New regulations from the Indian government
- Raising alarms, study sees trials migrating abroad
- Is Outsourcing of Clinical Trials Faulty?
- How to rescue a clinical trial
- Pfizer Plans to Disclose Payments Made to Clinical...
- Quintiles opens up Phase I Unit in India
- Microdosing could be a win/win for pharma, CROs
- PPD Extends its Reach to Eastern and Central Europe
- NIH Awards University of Texas $1.8M in Research G...
- Covance Opens Offices in Ukraine, Slovakia and Israel
- Covance expands into Eastern Europe and Middle East
- India to Conduct 5% Global Clinical Trials by 2012
- Executives are on the Move in the Outsourcing Indu...
- PRA International expands into southwest Asia
-
▼
February
(16)
No comments:
Post a Comment